Search
Harmony Biosciences Holdings Inc
HRMYAdd to Watchlist
38.595USD
+0.095+0.25%
Close 10-28 16:00（ET）
2.25BMarket Cap
15.27P/E TTM
Harmony Biosciences Holdings Inc (HRMY) Stock Price Target & Forecast
Analyst Rating
Based on 11 analysts giving stock ratings to Harmony Biosciences Holdings Inc in the past month.
Buy
2 Strong Buy
5 Buy
3 Hold
1 Sell
0 Strong Sell
Target Price
48.250USD+31.01%
HRMY Analyst Recommendation Trends
In the current month, HRMY has received 5 Buy Ratings, 3 Hold Ratings, and 1 Sell Ratings. HRMY average Analyst price target in the last month is 48.250.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2
2
1
1
1
1
1
1
5
5
5
5
5
5
5
8
3
3
3
4
4
4
4
1
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
11
11
10
11
11
11
11
11
HRMY Analyst Rating for Peer Comparison
Updated: Oct 29, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Biogen Inc
BIIB
8
16
12
1
0
37
Amgen Inc
AMGN
4
9
19
3
1
36
Vertex Pharmaceuticals Inc
VRTX
10
17
5
0
1
33
Eli Lilly and Co
LLY
10
19
3
1
0
33
Alnylam Pharmaceuticals Inc
ALNY
7
17
8
0
0
32
AbbVie Inc
ABBV
8
18
6
0
0
32
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Merck & Co Inc
MRK
7
16
8
0
0
31
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Bristol-Myers Squibb Co
BMY
5
6
18
1
0
30
Financial Forecasting
Based on analysts' estimates, HRMY EPS is projected to reach 1.135 in FY2026Q3, following reported EPS of 1.302 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
0.90
0.69
1.02
1.14
1.10
Actual
0.39
0.56
1.30
--
--
Surprise
-56.00%
-19.04%
+27.94%
--
--
FAQs
What is Harmony Biosciences Holdings Inc's expected revenue for the next quarter?
Harmony Biosciences Holdings Inc's expected revenue is 273.08M.
What is Harmony Biosciences Holdings Inc's price target?
Analysts forecast that Harmony Biosciences Holdings Inc's price target is USD 48.25, with the highest forecast at USD 70.00 and the lowest forecast at USD 30.00.
How have Harmony Biosciences Holdings IncHRMY's recent earnings per share performed?
The market expectation was USD 1.30, while Harmony Biosciences Holdings IncHRMY's earnings per share (EPS) for the previous quarter was USD 0.56. EPS for the next quarter is expected at USD 1.14.
What is the analyst rating for Harmony Biosciences Holdings Inc?
Based on the ratings of Harmony Biosciences Holdings Inc's stock from 11 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.